InnoPran XL and Polyethylene glycol 3350, electrolytes, and ascorbic acid
Determining the interaction of InnoPran XL and Polyethylene glycol 3350, electrolytes, and ascorbic acid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: propranolol
Brand name: Hemangeol, Inderal LA, Inderal XL, InnoPran XL, Inderal, InnoPran XL
Synonyms: n.a.
Generic Name: polyethylene glycol 3350 with electrolytes
Brand name: Colyte with Flavor Packs, GaviLyte-C, GoLYTELY, MoviPrep, NuLYTELY Orange, NuLYTELY with Flavor Packs, PEG-3350 with Electolytes, Plenvu, TriLyte with Flavor Packs, NuLYTELY, TriLyte, Suclear
Synonyms: Polyethylene glycol electrolyte solution, Polyethylene Glycol-Electrolyte Solution
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- InnoPran XL-Polyethylene glycol 3350, sodium and potassium salts
- InnoPran XL-Polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride, and potassium chloride
- InnoPran XL-Polyethylene glycol electrolyte solution
- InnoPran XL-Polyethylene Glycol-Electrolyte Solution (MoviPrep, Plenvu)
- InnoPran XL-Polyethylene Glycol-Electrolyte Solution and Bisacodyl
- InnoPran XL-Polyethylene Glycol-Electrolyte Solution Prep
- Polyethylene glycol 3350, electrolytes, and ascorbic acid-Inomax
- Polyethylene glycol 3350, electrolytes, and ascorbic acid-INOmax inhalation gas
- Polyethylene glycol 3350, electrolytes, and ascorbic acid-Inotersen
- Polyethylene glycol 3350, electrolytes, and ascorbic acid-Inotersen Sodium
- Polyethylene glycol 3350, electrolytes, and ascorbic acid-Inotersen Subcutaneous
- Polyethylene glycol 3350, electrolytes, and ascorbic acid-Inotuzumab ozogamicin